Search

Jon D Hoffmann

Examiner (ID: 9303, Phone: (571)272-9916 , Office: P/3746 )

Most Active Art Unit
3746
Art Unit(s)
3746
Total Applications
82
Issued Applications
44
Pending Applications
0
Abandoned Applications
38

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 6048834 [patent_doc_number] => 20110207824 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-25 [patent_title] => 'FORMULATION OF AN INJECTABLE PARACETAMOL SOLUTION, METHOD FOR PREPARING AND PACKAGING SUCH A SOLUTION AND DEVICE FOR PACKAGING SUCH A SOLUTION' [patent_app_type] => utility [patent_app_number] => 12/712412 [patent_app_country] => US [patent_app_date] => 2010-02-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 5875 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0207/20110207824.pdf [firstpage_image] =>[orig_patent_app_number] => 12712412 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/712412
FORMULATION OF AN INJECTABLE PARACETAMOL SOLUTION, METHOD FOR PREPARING AND PACKAGING SUCH A SOLUTION AND DEVICE FOR PACKAGING SUCH A SOLUTION Feb 24, 2010 Abandoned
Array ( [id] => 6514132 [patent_doc_number] => 20100216715 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-08-26 [patent_title] => 'FGF21 Derivatives With Albumin Binder A-B-C-D-E- And Their Use' [patent_app_type] => utility [patent_app_number] => 12/692227 [patent_app_country] => US [patent_app_date] => 2010-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 38442 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0216/20100216715.pdf [firstpage_image] =>[orig_patent_app_number] => 12692227 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/692227
FGF21 derivatives with albumin binder A-B-C-D-E- and their use Jan 21, 2010 Issued
Array ( [id] => 7766188 [patent_doc_number] => 20120034233 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-02-09 [patent_title] => 'Methods of Treating an Overweight or Obese Subject' [patent_app_type] => utility [patent_app_number] => 13/133060 [patent_app_country] => US [patent_app_date] => 2009-12-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 9132 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0034/20120034233.pdf [firstpage_image] =>[orig_patent_app_number] => 13133060 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/133060
Methods of treating an overweight or obese subject Dec 3, 2009 Issued
Array ( [id] => 7502515 [patent_doc_number] => 20110264026 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-10-27 [patent_title] => 'Azo Derivatives and Uses Thereof in Phototherapy' [patent_app_type] => utility [patent_app_number] => 12/679972 [patent_app_country] => US [patent_app_date] => 2009-11-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 42316 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0264/20110264026.pdf [firstpage_image] =>[orig_patent_app_number] => 12679972 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/679972
Azo Derivatives and Uses Thereof in Phototherapy Nov 22, 2009 Abandoned
Array ( [id] => 7561824 [patent_doc_number] => 20110275657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-11-10 [patent_title] => 'MELANOCORTIN RECEPTOR MODULATORS, PROCESS FOR PREPARING THEM AND USE THERE IN HUMAN MEDICINE AND COSMETICS' [patent_app_type] => utility [patent_app_number] => 13/126542 [patent_app_country] => US [patent_app_date] => 2009-11-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 29472 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20110275657.pdf [firstpage_image] =>[orig_patent_app_number] => 13126542 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/126542
Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics Nov 3, 2009 Issued
Array ( [id] => 6597165 [patent_doc_number] => 20100048645 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-02-25 [patent_title] => 'Solubilizing of metronidazole' [patent_app_type] => utility [patent_app_number] => 12/610996 [patent_app_country] => US [patent_app_date] => 2009-11-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4847 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20100048645.pdf [firstpage_image] =>[orig_patent_app_number] => 12610996 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/610996
Solubilizing of metronidazole Nov 1, 2009 Abandoned
Array ( [id] => 8963114 [patent_doc_number] => 20130202716 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'Treatment of Cancer Using Hypoxia Activated Prodrugs' [patent_app_type] => utility [patent_app_number] => 13/125303 [patent_app_country] => US [patent_app_date] => 2009-10-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 27777 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13125303 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/125303
Treatment of cancer using hypoxia activated prodrugs Oct 20, 2009 Issued
Array ( [id] => 6014961 [patent_doc_number] => 20110223213 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'HIGHLY PURE RANOLAZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF' [patent_app_type] => utility [patent_app_number] => 13/124479 [patent_app_country] => US [patent_app_date] => 2009-10-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 12520 [patent_no_of_claims] => 37 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0223/20110223213.pdf [firstpage_image] =>[orig_patent_app_number] => 13124479 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/124479
HIGHLY PURE RANOLAZINE OR A PHARMACEUTICALLY ACCEPTABLE SALT THEREOF Oct 12, 2009 Abandoned
Array ( [id] => 6167668 [patent_doc_number] => 20110195984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-08-11 [patent_title] => 'PEST CONTROL COMPOSITION AND PEST CONTROL METHOD' [patent_app_type] => utility [patent_app_number] => 13/123172 [patent_app_country] => US [patent_app_date] => 2009-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 9125 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0195/20110195984.pdf [firstpage_image] =>[orig_patent_app_number] => 13123172 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/123172
PEST CONTROL COMPOSITION AND PEST CONTROL METHOD Oct 8, 2009 Abandoned
Array ( [id] => 8713344 [patent_doc_number] => 08399484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-03-19 [patent_title] => 'Combination therapy for treating HCV infection' [patent_app_type] => utility [patent_app_number] => 12/560752 [patent_app_country] => US [patent_app_date] => 2009-09-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 10636 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12560752 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/560752
Combination therapy for treating HCV infection Sep 15, 2009 Issued
Array ( [id] => 6102642 [patent_doc_number] => 20110166135 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-07 [patent_title] => 'AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE' [patent_app_type] => utility [patent_app_number] => 13/062841 [patent_app_country] => US [patent_app_date] => 2009-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 24713 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0166/20110166135.pdf [firstpage_image] =>[orig_patent_app_number] => 13062841 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/062841
AROMATIC NITROGEN-CONTAINING 6-MEMBERED RING COMPOUNDS AND THEIR USE Sep 8, 2009 Abandoned
Array ( [id] => 7790497 [patent_doc_number] => 20120052053 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2012-03-01 [patent_title] => 'COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED ALPHA-SYNUCLEIN FUNCTION' [patent_app_type] => utility [patent_app_number] => 13/128222 [patent_app_country] => US [patent_app_date] => 2009-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 23118 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0052/20120052053.pdf [firstpage_image] =>[orig_patent_app_number] => 13128222 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/128222
COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED ALPHA-SYNUCLEIN FUNCTION Sep 3, 2009 Abandoned
Array ( [id] => 7545457 [patent_doc_number] => 08053429 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-11-08 [patent_title] => 'Solid oral dosage form containing an enhancer' [patent_app_type] => utility [patent_app_number] => 12/553196 [patent_app_country] => US [patent_app_date] => 2009-09-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 10775 [patent_no_of_claims] => 53 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/053/08053429.pdf [firstpage_image] =>[orig_patent_app_number] => 12553196 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/553196
Solid oral dosage form containing an enhancer Sep 2, 2009 Issued
Array ( [id] => 5959596 [patent_doc_number] => 20110183983 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-07-28 [patent_title] => 'HETEROCYCLIC COMPOUND AS PROTEIN KINASE INHIBITOR' [patent_app_type] => utility [patent_app_number] => 12/920243 [patent_app_country] => US [patent_app_date] => 2009-08-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 33822 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20110183983.pdf [firstpage_image] =>[orig_patent_app_number] => 12920243 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/920243
Heterocyclic compound as protein kinase inhibitor Aug 27, 2009 Issued
Array ( [id] => 5465695 [patent_doc_number] => 20090325895 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-12-31 [patent_title] => 'METHODS OF TREATING AN INFLAMMATORY-RELATED DISEASE' [patent_app_type] => utility [patent_app_number] => 12/548083 [patent_app_country] => US [patent_app_date] => 2009-08-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 23390 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0325/20090325895.pdf [firstpage_image] =>[orig_patent_app_number] => 12548083 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/548083
Methods of treating an inflammatory-related disease Aug 25, 2009 Issued
Array ( [id] => 6372752 [patent_doc_number] => 20100080807 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-04-01 [patent_title] => 'Methods and Compositions for Treating Viral Hemorrhagic Fever' [patent_app_type] => utility [patent_app_number] => 12/546992 [patent_app_country] => US [patent_app_date] => 2009-08-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 9792 [patent_no_of_claims] => 26 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0080/20100080807.pdf [firstpage_image] =>[orig_patent_app_number] => 12546992 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/546992
Methods and Compositions for Treating Viral Hemorrhagic Fever Aug 24, 2009 Abandoned
Array ( [id] => 6016780 [patent_doc_number] => 20110224206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-09-15 [patent_title] => 'TRIAZOLE COMPOUNDS THAT MODULATE HSP90 ACTIVITY' [patent_app_type] => utility [patent_app_number] => 13/057962 [patent_app_country] => US [patent_app_date] => 2009-08-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 49092 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20110224206.pdf [firstpage_image] =>[orig_patent_app_number] => 13057962 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/057962
Triazole compounds that modulate HSP90 activity Aug 6, 2009 Issued
Array ( [id] => 6186587 [patent_doc_number] => 20110124657 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2011-05-26 [patent_title] => 'METHOD FOR SCREENING OF 5HT7 RECEPTOR LIGANDS BASED ON A NEW PHARMACOPHORE MODEL AND A DESCRIPTOR\'S PROFILE FILTER' [patent_app_type] => utility [patent_app_number] => 13/055970 [patent_app_country] => US [patent_app_date] => 2009-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 4308 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20110124657.pdf [firstpage_image] =>[orig_patent_app_number] => 13055970 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/055970
METHOD FOR SCREENING OF 5HT7 RECEPTOR LIGANDS BASED ON A NEW PHARMACOPHORE MODEL AND A DESCRIPTOR'S PROFILE FILTER Jul 29, 2009 Abandoned
Array ( [id] => 7682049 [patent_doc_number] => 20100022759 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2010-01-28 [patent_title] => 'POLYMER AND FLUORESCENCE PROBE HAVING THE POLYMER' [patent_app_type] => utility [patent_app_number] => 12/509280 [patent_app_country] => US [patent_app_date] => 2009-07-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 8311 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0022/20100022759.pdf [firstpage_image] =>[orig_patent_app_number] => 12509280 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/509280
POLYMER AND FLUORESCENCE PROBE HAVING THE POLYMER Jul 23, 2009 Abandoned
Array ( [id] => 8745453 [patent_doc_number] => 20130085170 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-04-04 [patent_title] => 'COMPOSITIONS COMPRISING AMINO ACIDS, WITH PRO-ANGIOGENIC ACTIVITY' [patent_app_type] => utility [patent_app_number] => 12/996426 [patent_app_country] => US [patent_app_date] => 2009-06-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 3977 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12996426 [rel_patent_id] =>[rel_patent_doc_number] =>)
12/996426
Compositions comprising amino acids, with pro-angiogenic activity Jun 3, 2009 Issued
Menu